Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Faiferman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Surgical Oncology|January 1, 1981
Pathology of metastasizing tumors in nitrosomethyl urea-induced rat mammary carcinomaL Ghosh, J Nassauer, I Faiferman, et al.
Clinical Chemistry|February 1, 1980
Isolation and characterization of a human pancreas-specific proteinS T Nerenberg, R Prasad, L Pedersen, et al.
Clinical and Experimental Immunology|March 1, 1980
Isolation and characterization of a human liver and kidney-specific protein: the hepato-renal (H-R) antigenS T Nerenberg, R Prasad, P Inboriboon, et al.
The Journal of Allergy and Clinical Immunology|September 2, 1998
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjectsA Hamilton, I Faiferman, P Stober, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1996
A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug TrialI L Bernstein, D I Bernstein, J W Dubb, et al.
British Journal of Clinical Pharmacology|March 18, 2006
Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjectsD Singh, R Tal-Singer, I Faiferman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1997
Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonistJ Grossman, I Faiferman, J W Dubb, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Surgical Oncology|January 1, 1981
Pathology of metastasizing tumors in nitrosomethyl urea-induced rat mammary carcinomaL Ghosh, J Nassauer, I Faiferman, et al.
Clinical Chemistry|February 1, 1980
Isolation and characterization of a human pancreas-specific proteinS T Nerenberg, R Prasad, L Pedersen, et al.
Clinical and Experimental Immunology|March 1, 1980
Isolation and characterization of a human liver and kidney-specific protein: the hepato-renal (H-R) antigenS T Nerenberg, R Prasad, P Inboriboon, et al.
The Journal of Allergy and Clinical Immunology|September 2, 1998
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjectsA Hamilton, I Faiferman, P Stober, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1996
A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug TrialI L Bernstein, D I Bernstein, J W Dubb, et al.
British Journal of Clinical Pharmacology|March 18, 2006
Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjectsD Singh, R Tal-Singer, I Faiferman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1997
Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonistJ Grossman, I Faiferman, J W Dubb, et al.
Pageof 2